Esperion Therapeutics | ESPR - EPS Earnings Per Share


Esperion Therapeutics reported $-0.15 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2023
Amarin USD 0.08 0.11 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Cipla INR 15.2 1.52 Dec/2025
CSL USD 2.06 2.2 Jun/2025
Cytokinetics USD -2.55 1.43 Sep/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Geron USD -0.03 0.01 Sep/2025
Grifols EUR 0.26 0.06 Sep/2025
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD -0.51 1.62 Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024